XML 70 R39.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2024
Stock-Based Compensation  
Schedule of RSA activity and related information

Weighted-

Number of

Average Grant-Date

    

Shares

    

Fair Value

Unvested as of December 31, 2023

27,200

$

2.71

Vested

(6,028)

0.01

Repurchased

(21,172)

3.48

Unvested as of December 31, 2024

$

Schedule of fair values of stock options granted

December 31, 

    

2024

    

2023

Risk-free interest rate

3.80

%

4.13

%

Expected term (in years)

6.07

6.04

Expected volatility

94.31

%

87.86

%

Expected dividend yield

0.00

%

0.00

%

Schedule of stock option activity and related information

Weighted-Average

Aggregate

Remaining

Intrinsic

    

Number of Shares

    

Weighted - Average Exercise Price

    

Contractual Term (in years)

    

Value (in thousands)

Outstanding - December 31, 2023

2,382,933

$

8.51

$

8,084

Granted

6,736,822

14.67

Exercised

(38,427)

7.11

231

Forfeited or cancelled

(375,131)

10.29

Outstanding - December 31, 2024

8,706,197

$

13.21

8.76

$

2,104

Options vested and exercisable as of December 31, 2024

1,294,162

$

7.64

5.51

$

1,901

Options vested and expected to vest as of December 31, 2024

8,706,197

$

13.21

8.76

$

2,104

Schedule of stock-based compensation expense as reflected in condensed consolidated statements of operations and comprehensive loss

The Company recognized stock-based compensation expense related to the issuance of equity awards to employees in the consolidated statement of operations as follows (in thousands):

December 31,

2024

    

2023

Research and development

$

4,066

$

1,600

General and administrative

6,755

1,895

Total stock-based compensation expense

$

10,821

$

3,495